Skip to content

Care Outcomes for Chiropractic Outpatient Veterans

Care Outcomes for Chiropractic Outpatient Veterans Aim 3-pilot Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03254719
Acronym
COCOV
Enrollment
40
Registered
2017-08-18
Start date
2018-02-19
Completion date
2018-11-05
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Low Back Pain, PTSD

Keywords

Low Back Pain, Chiropractic, Veterans, PTSD, Depression, Anxiety

Brief summary

The primary objectives of this pilot trial are to evaluate the feasibility, safety and acceptability of an integrative care pathway that includes chiropractic care, for the coordinated care for Veterans Administration (VA) patients with chronic low back pain (cLBP), with an emphasis on those with mental health comorbidity, in preparation for the conduct of an appropriately powered multi-site randomized controlled trial (RCT). The secondary objectives are to collect study outcomes at the baseline visit (BV) and at weeks 3, 5, 7, and 10 to: 1) assess the success of collecting outcomes; 2) determine the outcome measures to use in a future RCT; and 3) determine preliminary intervention effect sizes and variability to aid in sample size determination for a future RCT. The investigators hypothesize that chiropractic care offers relief for pain and mental health symptoms through the direct effects of treatment-focused CMT, as well as through the indirect, non-specific effects of the team-based relationship with the clinician. This pilot study is a single-arm trial. All participants will be asked to complete study outcomes which include the Roland Morris Disability Questionnaire (RMDQ), LBP intensity and interference as measured by the Defense and Veterans Pain Rating Scale (DVPRS), as well as the Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder 7-item Scale (GAD-7), Alcohol Use Disorders Identification Test (AUDIT), Post-traumatic Stress Disorder Checklist-Civilian Version (PLC-C), self-care behaviors, Keele Start Back Screening Tool (STarT Back), Healing Encounters and Attitudes Lists (HEAL), Expectations for Complementary and Integrative Treatments Questionnaire (EXPECT), and Pain Intensity, Enjoyment of Life, General Activity Assessment Tool (PEG) questionnaires, and the Pain Assessment Screening Tool and Outcomes Registry (PASTOR) assessment, which includes measures of pain, disability, mental health, quality of life enjoyment and satisfaction. All participants will receive up to 10 weeks of chiropractic care and will complete outcome assessments at weeks 3, 5, 7, and 10 of the study.

Detailed description

The coinciding problems of chronic pain and mental illness are of great concern for patients seeking care within the Department of Veterans Affairs (VA) healthcare facilities. Of the 5.7 million veterans treated in VA facilities in 2012, more than half reported chronic pain syndromes, including chronic low back pain (cLBP). Veterans also experience many mental health comorbidities, such as depression, anxiety, post-traumatic stress disorder (PTSD), and substance abuse. Veterans in pain are often managed using prescription drugs, including opioids, psychotropic medications, and sleep agents. Non-pharmacological treatments for chronic pain, which also may provide relief of mental health symptoms, may be welcomed complementary therapies for veterans suffering from these conditions. Patients with musculoskeletal (MSK) pain and pain at multiple locations often report depression, anxiety and other mental health symptoms. Chronic pain may perpetuate mental health comorbidity as these conditions share common pathophysiological pathways. Research has shown that the non-specific effects of empathetic doctor communication and therapeutic alliance improves clinical outcomes. The investigators hypothesize that chiropractic care offers relief for pain and mental health symptoms through the direct effects of treatment-focused chiropractic manipulative therapy (CMT), as well as through the indirect, non-specific effects of the team-based relationship with the clinician. However, chiropractic care is not delivered in isolation from other treatments within the VA. Thus, the investigators will test a feasible, effective, patient-centered, guideline-based, integrative care model that integrates chiropractic into VA Patient Aligned Care Teams (PACTs). This integrative care pathway will involve primary care providers, mental health professionals, and doctors of chiropractic (DCs) engaged in the treatment of veterans with cLBP, with or without mental health comorbidity. While DCs are providing services within VA in increasing numbers over the past 13 years, as with any new service, adoption and appropriate placement faces challenges. Many VA providers may know little about the clinical approaches used by DCs. Similarly, DCs may not be fully aware of the processes involved in the delivery of primary care services within VA or the healthcare needs of veterans with mental illness. The purpose of this pilot clinical trial is to evaluate the feasibility, safety and patient perceptions of an integrative care pathway, developed through a consensus-based process, for the coordinated care for VA patients with cLBP and mental health comorbidity. As this is a pragmatic trial, chiropractic care will consist of usual chiropractic procedures for the management chronic low back pain (cLBP). Treatment approaches will be based on clinical evaluation, which may include diagnostic testing, to determine a working diagnosis, rule out pathology, and/or to screen for conditions requiring referral or other co-management. The investigators anticipate that chiropractic care often will include some form of chiropractic manipulative therapy (CMT). DCs will likely also recommend rehabilitative exercise, stretching, or nutritional and lifestyle advice based upon clinical findings and patient goals/preferences. The investigators will evaluate treatments through electronic health records (EHR) data abstraction following completion of chiropractic care at Week 10. As per typical VA care, DCs will monitor the participant's health status throughout the trial and initiate referrals as clinically indicated. Referrals to primary care and mental health providers will be consistent with the chiropractic integrated care pathway developed during a prior phase of the study. The investigators anticipate the most common communication and referral methods will occur through note-review and countersign procedures, which are already established among VA providers using the VA electronic health record, but may also occur in person or via phone conversations. Chiropractic care will be administered by licensed DCs who are current employees of the Iowa City VA Health Care System (ICVAHCS).

Interventions

All participants will be asked to complete study assessments at baseline visit, and weeks 3, 5, 7, and 10. Study participants will receive spinal manipulation and appropriate adjunctive therapies provided by doctors of chiropractic.

Sponsors

University of Iowa
CollaboratorOTHER
National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Palmer College of Chiropractic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Chiropractic care will be administered by licensed DCs who are current employees of the Iowa City VA Health Care System (ICVAHCS). Participants will receive chiropractic care at a frequency of 1-2 visits per week for a duration up to 10 weeks, with the frequency and duration of care individualized within established VA parameters. For this trial, the minimum treatment dose is 1 visit to the DC, while the maximum treatment dose is 12 visits.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Veterans age 18 years or older * Self-reported chronic LBP * Ability to sign informed consent form

Exclusion criteria

* Use of chiropractic care within the past 90 days * Impaired cognitive ability * Not a candidate for chiropractic care * Not able to attend chiropractic appointments * Identified as at risk for suicide

Design outcomes

Primary

MeasureTime frameDescription
Duration of Study RecruitmentFrom date of first participant enrolled to date last participant is enrolled, up to 8 months.As part of the feasibility assessment, the investigators will monitor the amount of time it takes to complete study recruitment and enrollment, and data collection. The investigators will monitor this through a data capture program.
Diversity of Patient DemographicsScreening through baselineAs part of the recruitment plan, investigators are trying to target female and minority veterans. Historically these groups have been underrepresented in veteran research. The investigators will review EHR data for participant demographics.
Number of Participants Engaged in Use of MyHealthEVet10 weeks from BaselineAs part of the feasibility assessment, investigators will monitor the number of study participants who enroll in and have at least one communication with MyHealthEVet. MyHealthEVet is an online communication tool designed to partner veterans and the veteran's health care team. It provides information on the veteran's health record and health topics as well as allows messaging communication between veterans and health care providers. Usage reports generated by MyHealthEVet will be analyzed to determine number of study participants engaged.
AcceptabilityAt Week 10 of the studyAcceptability will be assessed by conducting structured, qualitative exit interviews with participants and providers.
Number of Participants With Reported Adverse Events10 weeks from BaselineSafety for this study will be assessed by the number of adverse events counted and recorded.
Percentage of Participants Who Did Not Attend the Initial Chiropractic Visit, Withdrew, or Are Lost to Follow-up10 weeks from BaselineAs part of the feasibility assessment and ability to calculate a sample size for a full scale trial with subgroup analysis, investigators will monitor the percentage of missing data. This will include the percentage of participants who did not attend the initial chiropractic visit and withdraw or are lost to follow-up.

Secondary

MeasureTime frameDescription
Alcohol Use Disorders Identification Test (AUDIT)Baseline visit and week 10Developed by the World Health Organization (WHO), this 10-item screening questionnaire determines harmful or hazardous consumption of alcohol, correctly classifying 95% of people as having a clinical diagnosis of an alcohol abuse disorder (0-12, 0=No Alcohol Use).
PTSD Checklist-Civilian (PCL-C)Baseline visit and week 10This 17-item, self-reported instrument will assess PTSD. A total severity score is determined by summing scores from each of 17 items. A change of 5-10 points represents the minimum threshold for determining treatment response; a 10-20 point change represents a clinically significant change in PTSD symptom severity (17-85, 17=Not at all Severe PTSD Symptoms, 85=Extremely Severe PTSD Symptoms).
Roland Morris Low Back Pain Disability Questionnaire (RMDQ)Baseline visit and weeks 5 and 10The RMDQ is a widely used health status measure for low back pain. Scoring of the RMDQ ranges from 0-24, with a higher score indicating an increase in low back pain disability. (0-24, 0=No Disability, 24=Severe Disability)
Healing Encounters and Attitudes Lists (HEAL)After the initial chiropractic visitHEAL is a validated item-bank comprised of 6 domains developed through the Patient Reported Outcomes Measurement Information System (PROMIS) methodology. Investigators will use HEAL to assess nonspecific factors known to influence patient outcomes, including perceptions of the patient-provider connection, healthcare environment, treatment expectancy, spirituality, positive or negative outlook, and attitudes toward complementary and alternative medicine (CAM). A higher T-score represents more of the concept being measured. A T-score of 50 is equal to the mean and is considered normal. Lower numbers indicate values lower than the mean and higher numbers indicate values higher than the mean. Higher values are indicative of more positive perception. For example, a T-score of 55 on Patient-Provider Connection indicates that the respondent has a more positive perception toward the patient-provider connection than the general chronic condition population (half a standard deviation higher).
Pain, Enjoyment, and General Activity (PEG)Week 3 and Week 7The PEG is a 3-item tool to improve assessment and monitoring of chronic pain. The overall PEG-3 score ranges from 0-10 with 10 indicating more pain, more interference with enjoyment of life, and more interference with general activity. Questions assess average pain intensity (P) (AVERAGE pain in past week: 0-10, 0= No Pain, 10=Pain as bad as you can imagine), interference with enjoyment of life (E), and interference with general activity (G) (In past week, how pain interfered with...(0-10, 0=Does not interfere, 10=Completely interferes).
Pain Assessment Screening Tool and Outcomes Registry (PASTOR)Baseline visit and weeks 5 and 10PASTOR is an on-line data collection tool based on the NIH Patient Reported Outcomes Measurement Information System (PROMIS) and adopted by the DoD/VA Pain Management Task Force. Specific measures include the Defense & Veterans Pain Rating Scale (DVPRS), an enhanced 11-item (total range 0-10, 0=no pain, 10=worst pain) numeric rating scale (NRS) that improves on standard pain NRS by including a Faces Rating Scale component; 'traffic light' color-coding system to delineate mild, moderate and severe pain; and word descriptors, paired with 4, 0-10 NRS items to quantify the impact of pain on general activity, sleep, mood, and stress. PASTOR incorporates PROMIS measures for mental health conditions (PTSD, depression, anxiety, anger, and alcohol use), physical and social function, fatigue, and pain interference with daily activities to provide graphical representation of improvements or declines in patient status that are compared to matched US samples on age, race/ethnicity and sex.
STarT Back Screening ToolBaseline visit and week 10This is a 9-item, validated tool developed by Keele University to be used as a screening tool for patients with low back pain. It stratifies patients based on their prognosis of persistent disabling symptoms and allows practitioners to group patients into 3 categories (low, medium, or high risk of poor outcome).
Self-Efficacy for Managing Symptoms (SF8a)Baseline visit and week 10Developed by the Patient-Reported Outcomes Measurement Information System (PROMIS), this 8-item, self-reported tool will assess a person's level of confidence to manage/control symptoms, to manage their symptoms in different settings and to keep symptoms from interfering with work, sleep, relationships or recreational activities. Each question usually has five response options ranging in value from 1 to 5. The total raw score for a measure is converted to into a T-score for each participant. The T-score rescales the raw score into a standardized score with a mean of 50 and a standard deviation (SD) of 10. Therefore a person with a T-score of 40 is one SD below the mean. A higher PROMIS T-score represents more of the concept being measured. For example, a T-score of 55 on the PROMIS Self-Efficacy for Managing Symptoms indicates that the respondent has greater self-efficacy for managing their symptoms than the general chronic condition population (half a standard deviation higher).
Patient Health Questionnaire (PHQ-9)Baseline visit and week 10This instrument is self-reported with nine items and will be used to assess depressive disorder. Total scores range from 0 to 27 with a score of 10-14 considered to be in the moderate range (0-27, 0=No Depression, 27=Severe Depression). It has been tested in primary care settings and has a test-retest reliability of 0.81 to 0.96.
Generalized Anxiety Disorder-7 (GAD-7)Baseline visit and week 10This instrument is self-reported with seven items and will be used to assess generalized anxiety disorder. At a cut off score of 10 (0-21, 0=No Anxiety Disorder, 21=Severe Anxiety Disorder), it has a sensitivity of 0.89 and specificity of 0.82 for identifying patients with GAD in primary care settings.

Countries

United States

Participant flow

Participants by arm

ArmCount
Treatment Arm
All participants enrolled in the study will receive chiropractic care consistent with the usual chiropractic procedures for the management of chronic low back pain at the Iowa City VA Health Care System. Participants will also complete study assessments as described in outcomes. Study assessments: All participants will be asked to complete study assessments at baseline visit, and weeks 3, 5, 7, and 10. Study participants will receive spinal manipulation and appropriate adjunctive therapies provided by doctors of chiropractic.
40
Total40

Baseline characteristics

CharacteristicTreatment Arm
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
11 Participants
Age, Categorical
Between 18 and 65 years
29 Participants
Age, Continuous53.3 years
STANDARD_DEVIATION 15.1
Race/Ethnicity, Customized
Ethnicity
Hispanic or Latino
2 Participants
Race/Ethnicity, Customized
Ethnicity
Not Hispanic or Latino
38 Participants
Race/Ethnicity, Customized
Race
Declined to Answer
2 Participants
Race/Ethnicity, Customized
Race
Multi-racial
1 Participants
Race/Ethnicity, Customized
Race
Unknown
1 Participants
Race/Ethnicity, Customized
Race
White
36 Participants
Region of Enrollment
United States
40 participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
31 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 40
other
Total, other adverse events
5 / 40
serious
Total, serious adverse events
0 / 40

Outcome results

Primary

Acceptability

Acceptability will be assessed by conducting structured, qualitative exit interviews with participants and providers.

Time frame: At Week 10 of the study

Population: Acceptability of chiropractic service delivery as viewed by those veterans who were interviewed.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Treatment ArmAcceptabilityViewed as Positive10 Participants
Treatment ArmAcceptabilityViewed as Mixed Positive/Negative9 Participants
Treatment ArmAcceptabilityViewed as Negative5 Participants
Primary

Diversity of Patient Demographics

As part of the recruitment plan, investigators are trying to target female and minority veterans. Historically these groups have been underrepresented in veteran research. The investigators will review EHR data for participant demographics.

Time frame: Screening through baseline

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Treatment ArmDiversity of Patient DemographicsMulti-racial1 Participants
Treatment ArmDiversity of Patient DemographicsWhite36 Participants
Treatment ArmDiversity of Patient DemographicsOther or unspecified3 Participants
Treatment ArmDiversity of Patient DemographicsHispanic or Latino2 Participants
Treatment ArmDiversity of Patient DemographicsMale31 Participants
Treatment ArmDiversity of Patient Demographics18-35 years6 Participants
Treatment ArmDiversity of Patient Demographics36-54 years16 Participants
Treatment ArmDiversity of Patient Demographics55+ years18 Participants
Primary

Duration of Study Recruitment

As part of the feasibility assessment, the investigators will monitor the amount of time it takes to complete study recruitment and enrollment, and data collection. The investigators will monitor this through a data capture program.

Time frame: From date of first participant enrolled to date last participant is enrolled, up to 8 months.

ArmMeasureValue (NUMBER)
Treatment ArmDuration of Study Recruitment6 months
Primary

Number of Participants Engaged in Use of MyHealthEVet

As part of the feasibility assessment, investigators will monitor the number of study participants who enroll in and have at least one communication with MyHealthEVet. MyHealthEVet is an online communication tool designed to partner veterans and the veteran's health care team. It provides information on the veteran's health record and health topics as well as allows messaging communication between veterans and health care providers. Usage reports generated by MyHealthEVet will be analyzed to determine number of study participants engaged.

Time frame: 10 weeks from Baseline

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Treatment ArmNumber of Participants Engaged in Use of MyHealthEVet15 Participants
Primary

Number of Participants With Reported Adverse Events

Safety for this study will be assessed by the number of adverse events counted and recorded.

Time frame: 10 weeks from Baseline

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Treatment ArmNumber of Participants With Reported Adverse Events6 Participants
Primary

Percentage of Participants Who Did Not Attend the Initial Chiropractic Visit, Withdrew, or Are Lost to Follow-up

As part of the feasibility assessment and ability to calculate a sample size for a full scale trial with subgroup analysis, investigators will monitor the percentage of missing data. This will include the percentage of participants who did not attend the initial chiropractic visit and withdraw or are lost to follow-up.

Time frame: 10 weeks from Baseline

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Treatment ArmPercentage of Participants Who Did Not Attend the Initial Chiropractic Visit, Withdrew, or Are Lost to Follow-up8 Participants
Secondary

Alcohol Use Disorders Identification Test (AUDIT)

Developed by the World Health Organization (WHO), this 10-item screening questionnaire determines harmful or hazardous consumption of alcohol, correctly classifying 95% of people as having a clinical diagnosis of an alcohol abuse disorder (0-12, 0=No Alcohol Use).

Time frame: Baseline visit and week 10

ArmMeasureGroupValue (MEAN)Dispersion
Treatment ArmAlcohol Use Disorders Identification Test (AUDIT)Baseline2.2 score on a scaleStandard Deviation 2.8
Treatment ArmAlcohol Use Disorders Identification Test (AUDIT)Week 101.7 score on a scaleStandard Deviation 1.9
Secondary

Generalized Anxiety Disorder-7 (GAD-7)

This instrument is self-reported with seven items and will be used to assess generalized anxiety disorder. At a cut off score of 10 (0-21, 0=No Anxiety Disorder, 21=Severe Anxiety Disorder), it has a sensitivity of 0.89 and specificity of 0.82 for identifying patients with GAD in primary care settings.

Time frame: Baseline visit and week 10

ArmMeasureGroupValue (MEAN)Dispersion
Treatment ArmGeneralized Anxiety Disorder-7 (GAD-7)Baseline7.7 score on a scaleStandard Deviation 5.6
Treatment ArmGeneralized Anxiety Disorder-7 (GAD-7)Week 106.8 score on a scaleStandard Deviation 5.3
Secondary

Healing Encounters and Attitudes Lists (HEAL)

HEAL is a validated item-bank comprised of 6 domains developed through the Patient Reported Outcomes Measurement Information System (PROMIS) methodology. Investigators will use HEAL to assess nonspecific factors known to influence patient outcomes, including perceptions of the patient-provider connection, healthcare environment, treatment expectancy, spirituality, positive or negative outlook, and attitudes toward complementary and alternative medicine (CAM). A higher T-score represents more of the concept being measured. A T-score of 50 is equal to the mean and is considered normal. Lower numbers indicate values lower than the mean and higher numbers indicate values higher than the mean. Higher values are indicative of more positive perception. For example, a T-score of 55 on Patient-Provider Connection indicates that the respondent has a more positive perception toward the patient-provider connection than the general chronic condition population (half a standard deviation higher).

Time frame: After the initial chiropractic visit

ArmMeasureGroupValue (MEAN)Dispersion
Treatment ArmHealing Encounters and Attitudes Lists (HEAL)Patient-Provider Connection - T-Score60.9 score on a scaleStandard Deviation 10.6
Treatment ArmHealing Encounters and Attitudes Lists (HEAL)Healthcare Environment - T-Score54.4 score on a scaleStandard Deviation 8.4
Treatment ArmHealing Encounters and Attitudes Lists (HEAL)Treatment Expectancy - T-Score54.6 score on a scaleStandard Deviation 11.5
Treatment ArmHealing Encounters and Attitudes Lists (HEAL)Positive Outlook - T-Score52.0 score on a scaleStandard Deviation 10.4
Treatment ArmHealing Encounters and Attitudes Lists (HEAL)Spirituality - T-Score50.9 score on a scaleStandard Deviation 13.3
Treatment ArmHealing Encounters and Attitudes Lists (HEAL)Attitudes toward CAM - T-Score56.0 score on a scaleStandard Deviation 9.6
Secondary

Pain Assessment Screening Tool and Outcomes Registry (PASTOR)

PASTOR is an on-line data collection tool based on the NIH Patient Reported Outcomes Measurement Information System (PROMIS) and adopted by the DoD/VA Pain Management Task Force. Specific measures include the Defense & Veterans Pain Rating Scale (DVPRS), an enhanced 11-item (total range 0-10, 0=no pain, 10=worst pain) numeric rating scale (NRS) that improves on standard pain NRS by including a Faces Rating Scale component; 'traffic light' color-coding system to delineate mild, moderate and severe pain; and word descriptors, paired with 4, 0-10 NRS items to quantify the impact of pain on general activity, sleep, mood, and stress. PASTOR incorporates PROMIS measures for mental health conditions (PTSD, depression, anxiety, anger, and alcohol use), physical and social function, fatigue, and pain interference with daily activities to provide graphical representation of improvements or declines in patient status that are compared to matched US samples on age, race/ethnicity and sex.

Time frame: Baseline visit and weeks 5 and 10

Population: There are missing data when a participant was lost to follow-up or chose not to complete an item.

ArmMeasureGroupValue (MEAN)Dispersion
Treatment ArmPain Assessment Screening Tool and Outcomes Registry (PASTOR)Worst Pain, Baseline6.4 score on a scaleStandard Deviation 1.7
Treatment ArmPain Assessment Screening Tool and Outcomes Registry (PASTOR)Worst Pain, Week 55.7 score on a scaleStandard Deviation 2
Treatment ArmPain Assessment Screening Tool and Outcomes Registry (PASTOR)Worst Pain, Week 105.3 score on a scaleStandard Deviation 2.2
Treatment ArmPain Assessment Screening Tool and Outcomes Registry (PASTOR)Average Pain, Baseline5.4 score on a scaleStandard Deviation 1.4
Treatment ArmPain Assessment Screening Tool and Outcomes Registry (PASTOR)Average Pain, Week 54.8 score on a scaleStandard Deviation 1.8
Treatment ArmPain Assessment Screening Tool and Outcomes Registry (PASTOR)Average Pain, Week 103.9 score on a scaleStandard Deviation 2
Secondary

Pain, Enjoyment, and General Activity (PEG)

The PEG is a 3-item tool to improve assessment and monitoring of chronic pain. The overall PEG-3 score ranges from 0-10 with 10 indicating more pain, more interference with enjoyment of life, and more interference with general activity. Questions assess average pain intensity (P) (AVERAGE pain in past week: 0-10, 0= No Pain, 10=Pain as bad as you can imagine), interference with enjoyment of life (E), and interference with general activity (G) (In past week, how pain interfered with...(0-10, 0=Does not interfere, 10=Completely interferes).

Time frame: Week 3 and Week 7

ArmMeasureGroupValue (MEAN)Dispersion
Treatment ArmPain, Enjoyment, and General Activity (PEG)Average pain, Week 35.1 score on a scaleStandard Deviation 2
Treatment ArmPain, Enjoyment, and General Activity (PEG)Average pain, Week 74.8 score on a scaleStandard Deviation 2
Treatment ArmPain, Enjoyment, and General Activity (PEG)Enjoyment of Life Pain Interference, Week 35.3 score on a scaleStandard Deviation 2.2
Treatment ArmPain, Enjoyment, and General Activity (PEG)Enjoyment of Life Pain Interference, Week 74.7 score on a scaleStandard Deviation 2.5
Treatment ArmPain, Enjoyment, and General Activity (PEG)General Activity Pain Interference, Week 35.2 score on a scaleStandard Deviation 2.2
Treatment ArmPain, Enjoyment, and General Activity (PEG)General Activity Pain Interference, Week 74.7 score on a scaleStandard Deviation 2.7
Treatment ArmPain, Enjoyment, and General Activity (PEG)Overall PEG-3 Score, Week 35.2 score on a scaleStandard Deviation 2
Treatment ArmPain, Enjoyment, and General Activity (PEG)Overall PEG-3 Score, Week 74.7 score on a scaleStandard Deviation 2.3
Secondary

Patient Health Questionnaire (PHQ-9)

This instrument is self-reported with nine items and will be used to assess depressive disorder. Total scores range from 0 to 27 with a score of 10-14 considered to be in the moderate range (0-27, 0=No Depression, 27=Severe Depression). It has been tested in primary care settings and has a test-retest reliability of 0.81 to 0.96.

Time frame: Baseline visit and week 10

ArmMeasureGroupValue (MEAN)Dispersion
Treatment ArmPatient Health Questionnaire (PHQ-9)Baseline9.7 score on a scaleStandard Deviation 5.6
Treatment ArmPatient Health Questionnaire (PHQ-9)Week 108.6 score on a scaleStandard Deviation 5.8
Secondary

PTSD Checklist-Civilian (PCL-C)

This 17-item, self-reported instrument will assess PTSD. A total severity score is determined by summing scores from each of 17 items. A change of 5-10 points represents the minimum threshold for determining treatment response; a 10-20 point change represents a clinically significant change in PTSD symptom severity (17-85, 17=Not at all Severe PTSD Symptoms, 85=Extremely Severe PTSD Symptoms).

Time frame: Baseline visit and week 10

ArmMeasureGroupValue (MEAN)Dispersion
Treatment ArmPTSD Checklist-Civilian (PCL-C)Baseline40.3 score on a scaleStandard Deviation 18.1
Treatment ArmPTSD Checklist-Civilian (PCL-C)Week 1040.1 score on a scaleStandard Deviation 19.3
Secondary

Roland Morris Low Back Pain Disability Questionnaire (RMDQ)

The RMDQ is a widely used health status measure for low back pain. Scoring of the RMDQ ranges from 0-24, with a higher score indicating an increase in low back pain disability. (0-24, 0=No Disability, 24=Severe Disability)

Time frame: Baseline visit and weeks 5 and 10

ArmMeasureGroupValue (MEAN)Dispersion
Treatment ArmRoland Morris Low Back Pain Disability Questionnaire (RMDQ)Baseline12.9 score on a scaleStandard Deviation 5.1
Treatment ArmRoland Morris Low Back Pain Disability Questionnaire (RMDQ)Week 510.2 score on a scaleStandard Deviation 5.5
Treatment ArmRoland Morris Low Back Pain Disability Questionnaire (RMDQ)Week 109.6 score on a scaleStandard Deviation 6.2
Secondary

Self-Efficacy for Managing Symptoms (SF8a)

Developed by the Patient-Reported Outcomes Measurement Information System (PROMIS), this 8-item, self-reported tool will assess a person's level of confidence to manage/control symptoms, to manage their symptoms in different settings and to keep symptoms from interfering with work, sleep, relationships or recreational activities. Each question usually has five response options ranging in value from 1 to 5. The total raw score for a measure is converted to into a T-score for each participant. The T-score rescales the raw score into a standardized score with a mean of 50 and a standard deviation (SD) of 10. Therefore a person with a T-score of 40 is one SD below the mean. A higher PROMIS T-score represents more of the concept being measured. For example, a T-score of 55 on the PROMIS Self-Efficacy for Managing Symptoms indicates that the respondent has greater self-efficacy for managing their symptoms than the general chronic condition population (half a standard deviation higher).

Time frame: Baseline visit and week 10

Population: PROMIS - Self-Efficacy for Managing Symptoms - T score at Baseline and Week 10 follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Treatment ArmSelf-Efficacy for Managing Symptoms (SF8a)Baseline41.6 score on a scaleStandard Deviation 6.4
Treatment ArmSelf-Efficacy for Managing Symptoms (SF8a)Week 1043.5 score on a scaleStandard Deviation 8.2
Secondary

STarT Back Screening Tool

This is a 9-item, validated tool developed by Keele University to be used as a screening tool for patients with low back pain. It stratifies patients based on their prognosis of persistent disabling symptoms and allows practitioners to group patients into 3 categories (low, medium, or high risk of poor outcome).

Time frame: Baseline visit and week 10

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Treatment ArmSTarT Back Screening ToolWeek 10High Risk7 Participants
Treatment ArmSTarT Back Screening ToolBaselineLow Risk2 Participants
Treatment ArmSTarT Back Screening ToolBaselineMedium Risk17 Participants
Treatment ArmSTarT Back Screening ToolBaselineHigh Risk13 Participants
Treatment ArmSTarT Back Screening ToolBaselineMissing8 Participants
Treatment ArmSTarT Back Screening ToolWeek 10Low Risk9 Participants
Treatment ArmSTarT Back Screening ToolWeek 10Medium Risk12 Participants
Treatment ArmSTarT Back Screening ToolWeek 10Missing12 Participants

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026